ACRV ▲ +6.0% - Acrivon Therapeutics, Inc.
$ACRV - Acrivon to Present Late-Breaking Oral Plenary Presentation and Posters at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
04-NOV-2026 04:30 PM ET
Share this post
More filings for $ACRV
ACRV ▼ -1.1% - Acrivon Therapeutics, Inc.Oct 29, 2026ACRV ▲ +3.6% - Acrivon Therapeutics, Inc.Oct 20, 2026ACRV ▼ -0.5% - Acrivon Therapeutics, Inc.Sep 2, 2026ACRV ▲ +1.0% - Acrivon Therapeutics, Inc.Aug 31, 2026ACRV - Acrivon Therapeutics, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $ACRV filing history →💬 Comments
Loading comments…
Leave a comment